Chapter 1765： Boundless merit (1/2)

The big star Sun Xiaoxiang originally mentioned it a little bit, but he didn't expect that Li Tian would be so serious and his execution ability was so serious, so he immediately started to act.

This made Sun Xiaoxiang involuntarily start to take the initiative to get better to Li Tian, ​​after all, this man is so obedient, he must give a small reward.

…

Li Tian entered the medical laboratory.

Starting from the real disease, surgery, Li Tian currently has no relevant skills, so Li Tian should give priority to pharmaceuticals.

Chronic viral hepatitis B

This disease is very common in China, and it has not been able to root. It is also an infectious disease.

Chronic hepatitis B (chronic hepatitis B for short) refers to those who have tested positive for chronic hepatitis B virus, the course of the disease is more than half a year or the date of onset is not clear, and the clinical manifestations of chronic hepatitis.

The clinical manifestations include fatigue, fear of food, nausea, abdominal distension, and liver pain. The liver is large, the texture is medium hardness, and there is light tenderness. Severe conditions may be accompanied by chronic liver disease, spider veins, liver palms, splenomegaly, and liver function may be abnormal or persistent. According to clinical manifestations, it is divided into mild, moderate and severe.

Chronic hepatitis B virus carriers are those who test positive for hepatitis B virus, have no symptoms of chronic hepatitis, have no abnormalities in serum ALT and AST for more than 3 consecutive follow-ups within a year, and have normal liver histology.

…

According to statistics, there are currently close to 100 million people infected with hepatitis B in China, but with the advancement of science and medical conditions.

The new generation of children have been vaccinated against hepatitis B.

At present, the infection rate of hepatitis B among children has been declining year by year.

…

Therefore, the hepatitis B vaccine is already very advanced and does not require Li Tian to study it.

What he has to do is to deal with those hepatitis B patients who had poor medical conditions or were genetically infected.

Hepatitis B is divided into carriers, active hepatitis B, severe hepatitis, and hepatitis cirrhosis.

The worst is the latter.

The mildest one is the former. If the carrier can stabilize itself and not attack, it is actually the same as a normal person.

…

However, the severity of these illnesses needs to be treated with emphasis.

At present, the most troublesome aspect of this disease is that it is difficult to cut the roots. Basically, the roots cannot be cut. Many drugs are also treated conservatively.

…

Li Tian wants to study a drug to turn this infectious disease into history.

Sun Xiaoxiang heard that Li Tian was going to study this drug, and her face was a bit heavy.

This is a serious illness. If Li Tian can really research out a drug that can be completely cured, then Li Tian must be a medical figure who can be named forever in the history of medicine.

However, it is also certain that this medicine is different from acne and bruises.

Because there are many factors for acne, it is impossible to not grow at all, so acne products can be sold all the time, and someone will buy one.

And if Li Tian can really successfully develop a completely de-rooted hepatitis B drug, then the buyer will buy it, eat it, and it will be better, and there will be no need to worry about it all his life.

And if Li Tian only develops drugs that can be restrained but have to be taken all the year round, then he can make money for many years.

Because the medicine cannot be stopped.

but!

The big star Sun Xiaoxiang knows that Li Tian is that kind of person, and he will definitely research and develop towards cutting off roots.

For Li Tian, ​​making money is always secondary.

Therefore, even so, the star Sun Xiaoxiang is willing to support Li Tian.

After all, if this virus is missing from this world, it will be a super great good deed for all mankind.

Although in developed countries, the popularity of hepatitis B vaccine is high and the infection rate is low.

But in most developing countries, this disease is still very common.

If this drug can be successfully developed, at least 1 million people in the world will not die from this disease every year.